Synnocare Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$3.19M
- Investors
-
3
Synnocare General Information
Description
Developer of small molecule antitumor drugs targeting areas such as malignant tumors, autoimmune diseases, and central nervous system disorders. The company uses artificial intelligence and other technology to develop new drugs, it is a pharmaceutical enterprise empowered by AI (Artificial Intelligence) and Multi-Omics, it focuses on unmet clinical needs and undruggable targets in the field of malignant tumors and immunological diseases, and integrates "AI for Omics" technology into various stages of novel drug research and development, such as target discovery, drug molecular design and clinical trial design, enabling patients to have innovative drugs.
Contact Information
Website
www.synnocare.comCorporate Office
- Room 309, Building B, Number 1369 East Kangqiao Road
- Pudong New Area
- Shanghai
- China
Corporate Office
- Room 309, Building B, Number 1369 East Kangqiao Road
- Pudong New Area
- Shanghai
- China
Synnocare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 26-Jul-2023 | $3.19M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC | 05-Aug-2022 | Completed | Pre-Clinical Trials |
Synnocare Comparisons
Industry
Financing
Details
Synnocare Competitors (4)
One of Synnocare’s 4 competitors is Repare Therapeutics, a Formerly VC-backed company based in Saint-Laurent, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Repare Therapeutics | Formerly VC-backed | Saint-Laurent, Canada | ||||
| IDEAYA Biosciences | Formerly VC-backed | South San Francisco, CA | ||||
| Tango Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Abivax | Formerly PE-Backed | Paris, France |
Synnocare Patents
Synnocare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026195004-A1 | Vav1 degrader, and preparation method therefor and use thereof | Pending | 21-Mar-2025 | ||
| WO-2026195005-A1 | Vav1 degrader, preparation method therefor and use thereof | Pending | 21-Mar-2025 | ||
| WO-2026040999-A1 | Dhx9 inhibitor, preparation method therefor, and use thereof | Pending | 19-Aug-2024 | ||
| WO-2025232650-A1 | Kif18a inhibitor as well as preparation method therefor and use thereof | Pending | 07-May-2024 | ||
| EP-4810492-A1 | Nmt inhibitor, preparation method therefor, and use thereof | Pending | 16-Nov-2023 | A61P35/00 |
Synnocare Signals
Synnocare Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shanghai Yuanjin Herun Private Equity Fund Management | Growth/Expansion | Minority | ||
| Grains Valley Venture Capital | Venture Capital | Minority | ||
| Nanjing Dynamic balance Investment & Management | Growth/Expansion | Minority |
Synnocare FAQs
-
When was Synnocare founded?
Synnocare was founded in 2021.
-
Where is Synnocare headquartered?
Synnocare is headquartered in Shanghai, China.
-
What is the size of Synnocare?
Synnocare has 14 total employees.
-
What industry is Synnocare in?
Synnocare’s primary industry is Drug Discovery.
-
Is Synnocare a private or public company?
Synnocare is a Private company.
-
What is the current valuation of Synnocare?
The current valuation of Synnocare is .
-
What is Synnocare’s current revenue?
The current revenue for Synnocare is .
-
How much funding has Synnocare raised over time?
Synnocare has raised $5.71M.
-
Who are Synnocare’s investors?
Shanghai Yuanjin Herun Private Equity Fund Management, Grains Valley Venture Capital, and Nanjing Dynamic balance Investment & Management have invested in Synnocare.
-
Who are Synnocare’s competitors?
Repare Therapeutics, IDEAYA Biosciences, Tango Therapeutics, and Abivax are competitors of Synnocare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process